Belvedere Trading’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,114	Closed	-$99K	–	240
2024 Q1	$99K	Buy	+2,114	New	+$99K	﹤0.01%	120
2023 Q4	–	Sell	-3,404	Closed	-$101K	–	284
2023 Q3	$101K	Buy	+3,404	New	+$101K	﹤0.01%	79